Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1985; Volume 28,Issue 5
  • You have access
    Dopamine D2 receptor binding sites for agonists. A tetrahedral model.
    P Seeman, M Watanabe, D Grigoriadis, J L Tedesco, S R George, U Svensson, J L Nilsson and J L Neumeyer
    Molecular Pharmacology November 1985, 28 (5) 391-399;
  • You have access
    Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
    K K McMahon and M M Hosey
    Molecular Pharmacology November 1985, 28 (5) 400-409;
  • You have access
    The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.
    F J Ehlert
    Molecular Pharmacology November 1985, 28 (5) 410-421;
  • You have access
    Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
    J T Turner, C Ray-Prenger and D B Bylund
    Molecular Pharmacology November 1985, 28 (5) 422-430;
  • You have access
    Epinephrine-stimulated maintained rubidium efflux from guinea pig hepatocytes may involve alpha 1- and alpha 2-adrenoceptors.
    J M Henley
    Molecular Pharmacology November 1985, 28 (5) 431-435;
  • You have access
    Structure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones.
    P Culver, M Burch, C Potenza, L Wasserman, W Fenical and P Taylor
    Molecular Pharmacology November 1985, 28 (5) 436-444;
  • You have access
    Structure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Chemical, biological, and X-ray crystallographic studies.
    A S Kende, F H Ebetino, W B Drendel, M Sundaralingam, E Glover and A Poland
    Molecular Pharmacology November 1985, 28 (5) 445-453;
  • You have access
    Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.
    J D Moyer, J M Karle, N Malinowski, V E Marquez, M A Salam, L Malspeis and R L Cysyk
    Molecular Pharmacology November 1985, 28 (5) 454-460;
  • You have access
    Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
    S H Berger, C H Jenh, L F Johnson and F G Berger
    Molecular Pharmacology November 1985, 28 (5) 461-467;
  • You have access
    Immunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats.
    H Satoh, J R Gillette, H W Davies, R D Schulick and L R Pohl
    Molecular Pharmacology November 1985, 28 (5) 468-474;
  • You have access
    Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    R R Neubig, R D Gantzos and R S Brasier
    Molecular Pharmacology November 1985, 28 (5) 475-486;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 28, Issue 5
1 Nov 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics